- All sections
- C - Chemistrymetallurgy
- C12N - Microorganisms or enzymescompositions thereofpropagating, preserving, or maintaining microorganismsmutation or genetic engineeringculture media
- C12N 15/37 - Papovaviridae, e.g. papillomaviruses, polyomavirus, SV40
Patent holdings for IPC class C12N 15/37
Total number of patents in this class: 129
10-year publication summary
|
2
|
8
|
3
|
14
|
3
|
19
|
6
|
5
|
10
|
2
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Sinocelltech Ltd. | 80 |
14 |
| The Trustees of the University of Pennsylvania | 4317 |
11 |
| Xiamen University | 535 |
9 |
| Beijing Health Guard Biotechnology, Inc. | 11 |
8 |
| Institute of Basic Medical Sciences, Chinese Academy of Medical Sciences | 109 |
6 |
| Xiamen Innovax Biotech Co., Ltd. | 89 |
5 |
| Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. | 28 |
4 |
| Becton, Dickinson and Company | 7254 |
3 |
| Inovio Pharmaceuticals, Inc. | 319 |
3 |
| The Regents of the University of California | 19887 |
2 |
| Bioleaders Corporation | 59 |
2 |
| British Columbia Cancer Agency Branch | 192 |
2 |
| Daiichi Sankyo Company, Limited | 1862 |
2 |
| National Institutes of Biomedical Innovation, Health and Nutrition | 156 |
2 |
| Riken | 1692 |
2 |
| University of Cape Town | 257 |
2 |
| Synplogen Co., Ltd. | 26 |
2 |
| ISA Pharmaceuticals B.V. | 2 |
2 |
| The General Hospital Corporation | 4724 |
1 |
| Anaconda Pharma | 5 |
1 |
| Other owners | 46 |